Chemistry - An Asian Journal,
Journal Year:
2023,
Volume and Issue:
18(8)
Published: March 5, 2023
The
development
of
the
merger
a
Ni(II)
catalyst
with
an
appropriate
photocatalyst
under
visible-light
irradiation
provides
new
strategy
for
realizing
direct
functionalization
C(sp3
)-H
bonds.
Mechanistically,
whether
reduction
Ni
to
form
Ni(0)
species
is
necessary
in
dual
catalysis
still
remains
debate.
Herein,
DFT
calculations
were
carried
out
gain
mechanistic
insight
into
enantioselective
acylation
α-amino
bonds
furnish
ketones
via
photoredox
and
catalysis.
A
feasible
pathway
Ni(I)-Ni(III)-Ni(II)-Ni(III)-Ni(I)
cycle
suggested
sequential
elementary
steps
oxidative
addition,
single
electron
reduction,
radical
reductive
elimination
leading
final
product,
whereas
nickel
catalytic
cycle,
Ni(I)-Ni(0)-Ni(II)-Ni(III)-Ni(I),
might
not
be
dual-catalyzed
origin
stereoselectivity
this
reaction
also
discussed,
which
could
attributed
minimization
steric
hindrance
between
alkyl
moiety
part
phenyl
group
chiral
ligand.
ACS Catalysis,
Journal Year:
2024,
Volume and Issue:
14(24), P. 18734 - 18743
Published: Dec. 10, 2024
Enantiopure
γ-amino
butyric
acids
(GABA)
and
derivatives
have
important
applications
in
medicinal
chemistry,
especially
for
the
treatment
of
central
nervous
system
diseases.
Many
marketed
drugs
feature
this
moiety.
In
context,
we
developed
a
highly
enantioselective
catalytic
strategy
rapidly
forging
β-
or
β,γ-substituted
GABA
by
exploiting
an
unexplored
ternary
electron
donor–acceptor
(EDA)
complex
simultaneously
driven
visible
light
chiral
Ni
catalyst.
With
cooperative
system,
range
structurally
diverse
been
achieved
high
yields
with
good
enantio-
diastereoselectivities
(up
to
88%
yield,
>99%
ee,
>19:1
dr).
Mechanistic
studies
indicate
that
key
success
is
dual
role
catalyst,
which
not
only
promotes
formation
EDA
complexes
generated
from
redox-active
esters,
Hantzsch
catalyst
but
can
also
precisely
provide
asymmetric
induction.
The
synthetic
benefits
method
were
proved
enabling
easy
access
pharmaceuticals
related
bioactive
molecules
such
as
pregabalin,
baclofen,
rolipram,
phenibut.
Chemistry - An Asian Journal,
Journal Year:
2023,
Volume and Issue:
18(8)
Published: March 5, 2023
The
development
of
the
merger
a
Ni(II)
catalyst
with
an
appropriate
photocatalyst
under
visible-light
irradiation
provides
new
strategy
for
realizing
direct
functionalization
C(sp3
)-H
bonds.
Mechanistically,
whether
reduction
Ni
to
form
Ni(0)
species
is
necessary
in
dual
catalysis
still
remains
debate.
Herein,
DFT
calculations
were
carried
out
gain
mechanistic
insight
into
enantioselective
acylation
α-amino
bonds
furnish
ketones
via
photoredox
and
catalysis.
A
feasible
pathway
Ni(I)-Ni(III)-Ni(II)-Ni(III)-Ni(I)
cycle
suggested
sequential
elementary
steps
oxidative
addition,
single
electron
reduction,
radical
reductive
elimination
leading
final
product,
whereas
nickel
catalytic
cycle,
Ni(I)-Ni(0)-Ni(II)-Ni(III)-Ni(I),
might
not
be
dual-catalyzed
origin
stereoselectivity
this
reaction
also
discussed,
which
could
attributed
minimization
steric
hindrance
between
alkyl
moiety
part
phenyl
group
chiral
ligand.